change the use of anticoagulant therapy for venous thromboembolism (VTE)

October 2008

New Chest guidelines will change the use of anticoagulant therapy for venous thromboembolism (VTE).

Initial treatment. Prescribe low-molecular-weight heparins (LMWH) as the standard initial treatment for most patients.

But consider SC unfractionated heparin, IV unfractionated heparin, or fondaparinux (Arixtra) as alternatives.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

change the use of anticoagulant therapy for venous thromboembolism (VTE)
Cardiology rhabdomyolysis in patients taking both simvastatin and amiodarone (Cordarone, etc)
Cardiology Cleviprex (CLEV-a-prex) will be used to control blood pressure in hospitalized patients
Supplements garlic for high blood pressure
Supplements Vitamin K is showing up in more calcium supplements
Sleep Disorders Some drugs can WORSEN obstructive sleep apnea
Pediatrics treating bedwetting in children
medicines not getting required refrigeration or freezing
Antithrombotics Aggrenox or Plavix instead of aspirin to prevent RECURRENT stroke
Diabetes & Endocrinology Is there any proof that desiccated thyroid (Armour) works better than synthetics (Synthroid, etc)
Dyslipidemia whether Vytorin causes cancer
Infectious Diseases Now you can use real numbers to explain how antibiotic risks outweigh benefits for most acute respiratory infections